SEC Form 4 · accession 0000899243-18-012440
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James N Wilson
Director
Period of report
Mar 13, 2018
Accepted (ET)
May 10, 2018 · 6:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 13, 2018 | G | 10,665 | $0.00 | D | 1,361,202 | I | James N. Wilson and Pamela D. Wilson Trust |
| Common StockF1,F2 | May 7, 2018 | G | 16,000 | $0.00 | D | 1,345,202 | I | James N. Wilson and Pamela D. Wilson Trust |
| Common StockF2 | holding | — | — | — | 901,067 | I | James and Pamela Wilson Family Partners |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the corrected amount of shares which was previously inadvertently misstated.
- F2Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.